FDA Responds to Testimony Regarding Marketing of CBD Products | NORML
WASHINGTON, DC — A representative of the US Food and Drug Administration responded to day-long public testimony regarding the establishment of regulations governing the retail sale of CBD-infused products. On May 31, the agency held its first-ever public hearing dedicated to issues surrounding the “manufacturing, product quality, marketing, labeling, and sale” of hemp-derived CBD-infused retail products. NORML provided written testimony ahead […]
FDA Responds to Testimony Regarding Marketing of CBD Products | The Daily Chronic
http://www.thedailychronic.net/2019/93905/fda-responds-to-testimony-regarding-marketing-of-cbd-products/
